Mycophenolate Mofetil (CellCept, Myfenax, Myfortic)
Comprehensive guide to mycophenolate mofetil: uses, dosage, side effects, and precautions for transplant rejection prevention.

Mycophenolate mofetil is an immunosuppressant medication primarily used to prevent organ transplant rejection in kidney, heart, and liver transplants. Available under brand names like
CellCept
,Myfenax
, andMyfortic
, it works by inhibiting the proliferation of T- and B-lymphocytes, key cells in the immune response.In addition to transplant medicine, mycophenolate is used off-label for autoimmune diseases such as lupus nephritis, vasculitis, and certain types of arthritis, where it helps control overactive immune responses. This article covers its uses, how it works, dosage, side effects, precautions, and more, drawing from high-credibility medical sources.
About Mycophenolate Mofetil
Mycophenolate mofetil is a prodrug that is rapidly converted in the body to its active metabolite, mycophenolic acid (MPA). MPA selectively inhibits inosine monophosphate dehydrogenase (IMPDH), an enzyme crucial for the de novo pathway of purine synthesis in lymphocytes. This suppression reduces the production of guanosine nucleotides needed for DNA synthesis, effectively halting the proliferation of T- and B-cells without significantly affecting other cell types that use salvage pathways.
The medication comes in several formulations to improve tolerability and absorption:
- Oral capsules or tablets (CellCept, Myfenax): 250 mg capsules.
- Extended-release tablets (Myfortic): 180 mg or 360 mg, designed for once-daily dosing with delayed-release coating to reduce gastrointestinal upset.
- Oral suspension: Useful for pediatric patients or those with swallowing difficulties.
- Intravenous (IV) infusion: For patients unable to take oral medication.
Food affects absorption differently: immediate-release forms should be taken on an empty stomach, while Myfortic can be taken with food.
Key facts about Mycophenolate Mofetil
- Drug group: Immunosuppressant (antimetabolite).
- Available as: Capsules (250 mg), tablets (500 mg), extended-release tablets (180/360 mg), oral suspension (200 mg/ml), IV solution.
- Is there a brand version?: Yes,
CellCept
,Myfenax
(mycophenolate mofetil);Myfortic
(mycophenolate sodium). - Starting dose for transplants: Typically 1 g twice daily (immediate-release) or 720 mg twice daily (Myfortic), adjusted by weight and blood levels.
- Time to work: Steady-state levels reached within 6-7 days; clinical effects seen over weeks with combination therapy.
- Common side effects: Diarrhea, nausea, abdominal pain, infections.
- Is it safe in pregnancy?: No – causes birth defects and miscarriage. Use effective contraception.
When is Mycophenolate Mofetil prescribed?
Mycophenolate is FDA-approved for prophylaxis of organ rejection in renal, cardiac, and hepatic transplants, used concomitantly with corticosteroids and cyclosporine. It reduces acute rejection rates by 50% compared to azathioprine in clinical trials.
Primary indications:
- Kidney transplant rejection prevention: Standard first-line with tacrolimus or cyclosporine.
- Heart and liver transplants: Similar regimens, often with dose adjustments for hepatic impairment.
- Off-label uses: Lupus nephritis (reduces proteinuria), myasthenia gravis, inflammatory myopathies, uveitis, and vasculitis.
It is not used as monotherapy due to inadequate immunosuppression; always combined with other agents like calcineurin inhibitors and steroids.
How and when to take Mycophenolate Mofetil
Dosage is individualized based on transplant type, body surface area (in pediatrics), and monitoring of MPA levels to minimize toxicity while preventing rejection.
| Indication | Adult Dose (Immediate-Release) | Adult Dose (Myfortic) | Pediatric Dose |
|---|---|---|---|
| Kidney Transplant | 1 g twice daily | 720 mg twice daily | 600 mg/m² twice daily (max 2 g/day) |
| Heart Transplant | 1.5 g twice daily | 720 mg twice daily | Not established |
| Liver Transplant | 1.5 g twice daily (taper post-op) | Not recommended | Not established |
Administration tips:
- Take on an empty stomach (1 hour before or 2 hours after meals) for immediate-release to maximize absorption.
- Swallow whole; do not crush, chew, or open capsules.
- Shake oral suspension well; use provided syringe for accurate dosing.
- If a dose is missed, take as soon as remembered unless near next dose; do not double up.
- For IV use: Administer over ≥2 hours to avoid infusion reactions.
Blood level monitoring (area under the curve, AUC) is recommended in high-risk patients to target 30-60 mg·h/L and avoid toxicity.
Common questions about Mycophenolate Mofetil
How long do I take mycophenolate mofetil for?
Lifelong in most transplant patients to prevent chronic rejection, unless side effects necessitate discontinuation or conversion to alternatives like belatacept.
Can you drink alcohol while taking it?
Moderate alcohol may be permissible but consult your doctor; it can exacerbate GI side effects and interact with liver function monitoring.
Is mycophenolate mofetil safe in breastfeeding?
No – excretes into breast milk and may harm infant immune system. Pump and discard milk or use formula.
Does mycophenolate mofetil cause hair loss?
Hair loss is uncommon (<5%); more often associated with other immunosuppressants like cyclosporine.
Side effects of Mycophenolate Mofetil
Mycophenolate commonly causes gastrointestinal disturbances due to high concentrations in the gut mucosa. Serious risks include infections, hematologic toxicity, and malignancy from chronic immunosuppression.
Common side effects (affecting >10%):
- Diarrhea (up to 30%)
- Nausea/vomiting (20%)
- Abdominal pain (15%)
- Headache (10%)
- Hypertension, peripheral edema
- Leukopenia, anemia
Serious side effects (report immediately):
- Infections: Increased risk of bacterial (e.g., pneumonia), viral (CMV, BK virus nephropathy, shingles), fungal, and opportunistic infections like PML (progressive multifocal leukoencephalopathy).
- Hematologic: Neutropenia (<1,300/mm³), thrombocytopenia, pure red cell aplasia.
- GI: Colitis, bleeding ulcers, perforation.
- Malignancy: Skin cancer, lymphoma (dose/duration-dependent).
- Reproductive: Miscarriage, congenital malformations (Category D).
Symptoms requiring urgent care: fever, chills, sore throat, unusual bruising/bleeding, severe diarrhea, vision changes, muscle weakness, yellowing skin.
How to cope with side effects of Mycophenolate Mofetil
- Diarrhea/nausea: Switch to Myfortic (enteric-coated, 30% less GI events); take antacids (avoid magnesium/aluminum); eat small bland meals.
- Infection prevention: Hand hygiene, vaccinations (inactivated only), avoid crowds; prophylactic antivirals/antibiotics as prescribed.
- Blood count drops: Regular CBC monitoring; dose reduction or temporary hold.
- Sun protection: Use SPF 50+, cover skin to reduce skin cancer risk.
Pregnancy and fertility while taking Mycophenolate Mofetil
Teratogenic: Causes specific birth defects (ear, heart, kidney malformations); absolute contraindication in pregnancy. Pregnancy test required before starting; two forms of contraception mandatory for 6 weeks before, during, and 6 weeks after therapy in women of childbearing potential.
- Men: Use contraception; semen may carry risk (theoretical).
- Fertility: May impair spermatogenesis; reversible upon discontinuation.
If pregnancy occurs, discontinue immediately and report to transplant team.
Cautions of Mycophenolate Mofetil
Use caution in:
- Active infections, GI ulcers, renal impairment (adjust dose if CrCl <25 mL/min).
- Hepatitis B/C carriers (risk of reactivation).
- High-risk malignancy patients.
- Polysorbate 80 allergy (IV form).
Drug interactions: Live vaccines contraindicated; avoid with azathioprine; antacids, cholestyramine reduce absorption; monitor with acyclovir/ganciclovir (increased myelosuppression).
Alternatives to Mycophenolate Mofetil
| Drug | Mechanism | Pros | Cons |
|---|---|---|---|
| Azathioprine | Purine analog | Cheaper, less GI toxicity | Higher malignancy risk, TPMT testing needed |
| Tacrolimus | Calcineurin inhibitor | Potent, once-daily option | Nephrotoxicity, neurotoxicity |
| Belatacept | Costimulation blocker | Organ-sparing | IV only, infection risk |
| mTOR inhibitors (Everolimus) | mTOR inhibitor | Anti-proliferative, anti-cancer | Delayed wound healing |
Interactions with other medicines, alcohol, and more
Major interactions:
- Increases toxicity: Acyclovir, ganciclovir, proton pump inhibitors (via OAT transporters).
- Decreases exposure: Bile acid sequestrants, magnesium/aluminum antacids, PPIs (monitor levels).
- Vaccines: Avoid live vaccines (MMR, varicella, oral polio).
- Alcohol: Limit to avoid GI/liver strain.
- Herbals: St. John’s wort induces metabolism.
Frequently Asked Questions (FAQs)
Can mycophenolate mofetil be crushed?
No – immediate-release capsules contain powder that must not be crushed; use suspension if needed. Myfortic tablets cannot be crushed due to enteric coating.
Does mycophenolate mofetil cause weight gain?
Mild weight gain possible from edema or steroids; monitor diet and BP.
How long do side effects last?
GI effects often improve after 1-2 weeks; persistent issues may require dose adjustment or switch.
Can I stop taking it suddenly?
No – risk of acute rejection; taper under medical supervision.
Is monitoring required?
Yes – weekly CBC first month, then monthly; MPA levels if toxicity suspected.
References
- Mycophenolate mofetil (oral route) – Mayo Clinic — Mayo Foundation for Medical Education and Research. 2023-10-01. https://www.mayoclinic.org/drugs-supplements/mycophenolate-mofetil-oral-route/description/drg-20073191
- 10 CellCept Side Effects You Should Know About — GoodRx. 2024-05-15. https://www.goodrx.com/cellcept/common-side-effects
- Mycophenolate: MedlinePlus Drug Information — U.S. National Library of Medicine. 2025-01-01. https://medlineplus.gov/druginfo/meds/a601081.html
- Mycophenolate (Cellcept, Myfortic, and others): Uses, Side Effects — WebMD. 2024-08-20. https://www.webmd.com/drugs/2/drug-4068-2108/mycophenolate-mofetil-oral/mycophenolate-mofetil-oral/details
- CellCept® (mycophenolate mofetil) – Information for Patients — Genentech, Inc. 2024-03-12. https://www.gene.com/patients/medicines/cellcept
- Mycophenolate (CellCept): Uses & Side Effects — Cleveland Clinic. 2024-11-05. https://my.clevelandclinic.org/health/drugs/18497-mycophenolate-tablets
- Mycophenolate | Side-effects, uses, time to work — Arthritis Research UK. 2023-07-18. https://www.arthritis-uk.org/information-and-support/understanding-arthritis/arthritis-treatments/drugs/mycophenolate/
Read full bio of medha deb
















